Novartis goes before India's Supreme Court this week to seek patent production for a key cancer drug in a case that could deliver far-reaching ramifications for pharmaceutical companies operating here.
WSJ.com: What's News US, Wall Street Journal
Sun, 08/19/2012 - 7:14pm
Novartis goes before India's Supreme Court this week to seek patent production for a key cancer drug in a case that could deliver far-reaching ramifications for pharmaceutical companies operating here.